Show simple item record

Urine TB lipoarabinomannan (LAM) predicts mortality in hospitalized HIV-infected children.

dc.contributor.authorLaCourse, SM
dc.contributor.authorCranmer, LM
dc.contributor.authorNjuguna, IN
dc.contributor.authorGatimu, J
dc.contributor.authorStern, J
dc.contributor.authorWalson, JL
dc.contributor.authorWamalwa, D
dc.contributor.authorJohn-Stewart, G
dc.contributor.authorPavlinac, P
dc.date.accessioned2018-01-16T05:50:25Z
dc.date.available2018-01-16T05:50:25Z
dc.date.issued2018
dc.identifier.citation10.1093/cid/ciy011.en_US
dc.identifier.urihttps://www.ncbi.nlm.nih.gov/pubmed/29324985
dc.identifier.urihttps://academic.oup.com/cid/advance-article-abstract/doi/10.1093/cid/ciy011/4792803
dc.identifier.urihttp://hdl.handle.net/11295/102355
dc.description.abstractDespite diagnostic performance limitations, urine lipoarabinomannan (LAM) predicts death in HIV-infected adults with TB. Pediatric data are limited. Among 137 hospitalized HIV-infected children, mortality was 4.9-fold higher among LAM-positives (127 vs. 31/100 py, aHR 4.92 [95%CI 1.79-13.49]; p=0.002). LAM identifies HIV-infected children at risk for death potentially missed by respiratory sampling.en_US
dc.language.isoenen_US
dc.publisherUniversity of Nairobien_US
dc.rightsAttribution-NonCommercial-NoDerivs 3.0 United States*
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/3.0/us/*
dc.subjectHIV; children; lipoarabinomannan; mortality; tuberculosis; urineen_US
dc.titleUrine TB lipoarabinomannan (LAM) predicts mortality in hospitalized HIV-infected children.en_US
dc.typeArticleen_US


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record

Attribution-NonCommercial-NoDerivs 3.0 United States
Except where otherwise noted, this item's license is described as Attribution-NonCommercial-NoDerivs 3.0 United States